A reduced expression level of TNFAIP3 is observed in monocytes of RRMS patient [81], whereas an increased expression of TNFAIP3 has been found in the lesions of post-mortem brain tissue of MS patients [82]. Here, TNFAIP3 is linked to myeloid sarcoma.